SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 57 filers reported holding SYNTHETIC BIOLOGICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $32,000 | -23.8% | 132,000 | 0.0% | 0.00% | -20.0% |
| Q1 2018 | $42,000 | +7.7% | 132,000 | +71.4% | 0.01% | 0.0% |
| Q4 2017 | $39,000 | -15.2% | 77,000 | +57.1% | 0.01% | -16.7% |
| Q3 2017 | $46,000 | +31.4% | 49,000 | -21.0% | 0.01% | +20.0% |
| Q2 2017 | $35,000 | +12.9% | 62,000 | +26.5% | 0.01% | +25.0% |
| Q1 2017 | $31,000 | +287.5% | 49,000 | +345.5% | 0.00% | +300.0% |
| Q4 2016 | $8,000 | -78.9% | 11,000 | -50.0% | 0.00% | -83.3% |
| Q3 2016 | $38,000 | -5.0% | 22,000 | 0.0% | 0.01% | -14.3% |
| Q2 2016 | $40,000 | -23.1% | 22,000 | 0.0% | 0.01% | -22.2% |
| Q1 2016 | $52,000 | +4.0% | 22,000 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $50,000 | 0.0% | 22,000 | 0.0% | 0.01% | -10.0% |
| Q3 2015 | $50,000 | +47.1% | 22,000 | +83.3% | 0.01% | +66.7% |
| Q2 2015 | $34,000 | +30.8% | 12,000 | 0.0% | 0.01% | +50.0% |
| Q1 2015 | $26,000 | +44.4% | 12,000 | 0.0% | 0.00% | +33.3% |
| Q4 2014 | $18,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,034,949 | $1,553,000 | 2.72% |
| Third Security, LLC | 13,238,268 | $10,095,000 | 0.54% |
| MSD Partners, L.P. | 4,118,402 | $3,141,000 | 0.16% |
| SABBY MANAGEMENT, LLC | 3,031,953 | $2,312,000 | 0.13% |
| Alyeska Investment Group, L.P. | 10,000,000 | $7,626,000 | 0.06% |
| BARD ASSOCIATES INC | 87,999 | $67,000 | 0.03% |
| Alyeska Investment Group, L.P. | 4,586,592 | $3,498,000 | 0.03% |
| FRANKLIN STREET ADVISORS INC /NC | 126,000 | $96,000 | 0.02% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,000,000 | $763,000,000 | 0.02% |
| HAMILTON LANE ADVISORS LLC | 23,855 | $18,000 | 0.01% |